Skip to content
← Full study record

NCT00304070 · OUTCOME

Five Year Event-free Survival (EFS)

Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor · Source last updated 2024-02-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Estimated probability five year EFS
Interval / dispersion
95% Confidence Interval
Time frame
Up to five years after enrollment

What was measured

The model used for comparison will be an exponential model with a constant failure rate of 0.053 (stratum I), 0.347 (stratum II), 0.602 (stratum III and IV) per year for the first two years and 0 after that. The one-sample one-sided log-rank test comparing the observed data with the hypothesized model (Woolson, 1981) of size 0.05 will be used to assess whether the data are consistent with the target models. Since this test has independent increments, the method of Lan and DeMets will be used to derive the p-values for testing procedure.

Groups in this outcome

Stratum 1

Stage I Disease (surgery, observation)

Stratum 2

Stage II Disease (surgery, observation)

Stratum 3

Stage III OR IV Disease (chemotherapy)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Stratum 124
Stratum 215
Stratum 339

Reported measurements

Source class 1
Values in Estimated probability five year EFS · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Stratum 10.86Not reported0.620.95Not reported
Stratum 20.53Not reported0.260.74Not reported
Stratum 30.51Not reported0.330.66Not reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    group Description
    We will test the 2-year EFS is 90% using the asymptotic distribution of the complementary log-log distribution of the Kaplan-Meier (KM) estimate.
    group Ids
    1. OG000
    non Inferiority Type
    OTHER
    p Value
    0.44
    param Type
    2 Year EFS
    param Value
    0.89
    statistical Method
    2-year KM estimate
  2. ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    group Description
    We will test the 2-year EFS is 50% using the asymptotic distribution of the complementary log-log distribution of the Kaplan-Meier (KM) estimate.
    group Ids
    1. OG001
    non Inferiority Type
    OTHER
    p Value
    0.40
    param Type
    2 Year EFS
    param Value
    0.53
    statistical Method
    2-year KM estimate
  3. ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    group Description
    We will test the 2-year EFS is 15% using the asymptotic distribution of the complementary log-log distribution of the Kaplan-Meier (KM) estimate.
    group Ids
    1. OG002
    non Inferiority Type
    OTHER
    p Value
    0.00000853
    param Type
    2 Year EFS
    param Value
    0.55
    statistical Method
    2-year KM estimate
Complete source fields
analyses
  1. ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    group Description
    We will test the 2-year EFS is 90% using the asymptotic distribution of the complementary log-log distribution of the Kaplan-Meier (KM) estimate.
    group Ids
    1. OG000
    non Inferiority Type
    OTHER
    p Value
    0.44
    param Type
    2 Year EFS
    param Value
    0.89
    statistical Method
    2-year KM estimate
  2. ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    group Description
    We will test the 2-year EFS is 50% using the asymptotic distribution of the complementary log-log distribution of the Kaplan-Meier (KM) estimate.
    group Ids
    1. OG001
    non Inferiority Type
    OTHER
    p Value
    0.40
    param Type
    2 Year EFS
    param Value
    0.53
    statistical Method
    2-year KM estimate
  3. ci Num Sides
    TWO_SIDED
    ci Pct Value
    95
    group Description
    We will test the 2-year EFS is 15% using the asymptotic distribution of the complementary log-log distribution of the Kaplan-Meier (KM) estimate.
    group Ids
    1. OG002
    non Inferiority Type
    OTHER
    p Value
    0.00000853
    param Type
    2 Year EFS
    param Value
    0.55
    statistical Method
    2-year KM estimate
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.62
        upper Limit
        0.95
        value
        0.86
      2. group Id
        OG001
        lower Limit
        0.26
        upper Limit
        0.74
        value
        0.53
      3. group Id
        OG002
        lower Limit
        0.33
        upper Limit
        0.66
        value
        0.51
denoms
  1. counts
    1. group Id
      OG000
      value
      24
    2. group Id
      OG001
      value
      15
    3. group Id
      OG002
      value
      39
    units
    Participants
description
The model used for comparison will be an exponential model with a constant failure rate of 0.053 (stratum I), 0.347 (stratum II), 0.602 (stratum III and IV) per year for the first two years and 0 after that. The one-sample one-sided log-rank test comparing the observed data with the hypothesized model (Woolson, 1981) of size 0.05 will be used to assess whether the data are consistent with the target models. Since this test has independent increments, the method of Lan and DeMets will be used to derive the p-values for testing procedure.
dispersion Type
95% Confidence Interval
groups
  1. description
    Stage I Disease (surgery, observation)
    id
    OG000
    title
    Stratum 1
  2. description
    Stage II Disease (surgery, observation)
    id
    OG001
    title
    Stratum 2
  3. description
    Stage III OR IV Disease (chemotherapy)
    id
    OG002
    title
    Stratum 3
param Type
NUMBER
reporting Status
POSTED
time Frame
Up to five years after enrollment
title
Five Year Event-free Survival (EFS)
type
PRIMARY
unit Of Measure
Estimated probability five year EFS

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice